25C-NBOH

Source: Wikipedia, the free encyclopedia.
25C-NBOH
Legal status
Legal status
Identifiers
  • 2-({[2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol
JSmol)
  • COc1cc(Cl)c(OC)cc1CCNCc2ccccc2O
  • InChI=1S/C17H20ClNO3/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-19-11-13-5-3-4-6-15(13)20/h3-6,9-10,19-20H,7-8,11H2,1-2H3
  • Key:VHWXICYYQMMZCW-UHFFFAOYSA-N

25-C-NBOH (2C-C-NBOH, NBOH-2CC) is a derivative of the phenethylamine derived hallucinogen

serotonin receptor affinity to the better-known compound 25C-NBOMe.[2][3]

Analogues and derivatives

Analytical chemistry

25C-NBOH undergoes degradation under routine

GC/MS may be used for 25C-NBOH analysis.[6][7]

Legality

United Kingdom

This substance is a

Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[8]

References

  1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. PMID 24397362
    .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.